Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: The case of bisoprolol

MLA

Joyce S. Macwan, et al. “Application of Physiologically Based Biopharmaceutics Modeling to Understand the Impact of Dissolution Differences on in Vivo Performance of Immediate Release Products: The Case of Bisoprolol.” CPT: Pharmacometrics & Systems Pharmacology, vol. 10, no. 6, June 2021, pp. 622–32. EBSCOhost, https://doi.org/10.1002/psp4.12634.

APA

Joyce S. Macwan, Grace Fraczkiewicz, Mauro Bertolino, Phillip Krüger, & Sheila‐Annie Peters. (2021). Application of physiologically based biopharmaceutics modeling to understand the impact of dissolution differences on in vivo performance of immediate release products: The case of bisoprolol. CPT: Pharmacometrics & Systems Pharmacology, 10(6), 622–632. https://doi.org/10.1002/psp4.12634

Chicago

Joyce S. Macwan, Grace Fraczkiewicz, Mauro Bertolino, Phillip Krüger, and Sheila‐Annie Peters. 2021. “Application of Physiologically Based Biopharmaceutics Modeling to Understand the Impact of Dissolution Differences on in Vivo Performance of Immediate Release Products: The Case of Bisoprolol.” CPT: Pharmacometrics & Systems Pharmacology 10 (6): 622–32. doi:10.1002/psp4.12634.